Investors Snag ITCI 47.1% Cheaper Than Its Secondary Stock Offering
April 08, 2020 at 11:11 AM EDT
Looking back to 92 days ago, Intra-Cellular Therapies Inc (ITCI) priced a 10,000,000 share secondary stock offering at $29.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..